Efficacy and safety of alfacalcidol in Chinese postmenopausal women aged over 65 with osteoporosis or osteopenia: An open label, non-comparative, post marketing observational study

This study aimed to explore the therapeutic efficacy and safety of alfacalcidol among Chinese postmenopausal women (age >65 years) with osteoporosis or osteopenia. A total of 62 postmenopausal women with osteoporosis or osteopenia (>65 years) were recruited from urban residential community of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Nan, Jiang, Yan, He, Shuli, Zhao, Zhen, Sun, Jing, Li, Mei, Wang, Ou, Xing, Xiaoping, Xia, Weibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393057/
https://www.ncbi.nlm.nih.gov/pubmed/30461612
http://dx.doi.org/10.1097/MD.0000000000013159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393057/
https://www.ncbi.nlm.nih.gov/pubmed/30461612
http://dx.doi.org/10.1097/MD.0000000000013159

Ejemplares similares